Actively Recruiting
Multi-omics Research of Idopathic Normal Pressure Hydrocephalus (iNPH)
Led by Second Affiliated Hospital, School of Medicine, Zhejiang University · Updated on 2026-04-24
40
Participants Needed
1
Research Sites
328 weeks
Total Duration
On this page
Sponsors
S
Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead Sponsor
W
Westlake University
Collaborating Sponsor
AI-Summary
What this Trial Is About
The research is designed to study the prognostic factors of ventriculoperitoneal (VP) shunt for iNPH by multi-omics research
CONDITIONS
Official Title
Multi-omics Research of Idopathic Normal Pressure Hydrocephalus (iNPH)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 60 years
- Diagnosis of iNPH based on clinical assessment
- Participant is able to give written informed consent
You will not qualify if you...
- Combining Alzheimer's disease and Parkinson's disease and other nervous system diseases
- Participant is not medically available for shunt surgery
- Secondary NPH
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The second affliated hospital of zhejiang university
Hangzhou, Zhejiang, China, 310009
Actively Recruiting
Research Team
J
Junming Zhu, M.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here